188 related articles for article (PubMed ID: 27171431)
1. Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.
Munthe S; Petterson SA; Dahlrot RH; Poulsen FR; Hansen S; Kristensen BW
PLoS One; 2016; 11(5):e0155106. PubMed ID: 27171431
[TBL] [Abstract][Full Text] [Related]
2. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
[TBL] [Abstract][Full Text] [Related]
3. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
4. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
[TBL] [Abstract][Full Text] [Related]
5. Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids.
Kolenda J; Jensen SS; Aaberg-Jessen C; Christensen K; Andersen C; Brünner N; Kristensen BW
J Neurooncol; 2011 May; 103(1):43-58. PubMed ID: 20835751
[TBL] [Abstract][Full Text] [Related]
6. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
7. Detection of cancer stem cells from the C6 glioma cell line.
Zhou XD; Wang XY; Qu FJ; Zhong YH; Lu XD; Zhao P; Wang DH; Huang QB; Zhang L; Li XG
J Int Med Res; 2009; 37(2):503-10. PubMed ID: 19383245
[TBL] [Abstract][Full Text] [Related]
8. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T
Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.
Jensen SS; Meyer M; Petterson SA; Halle B; Rosager AM; Aaberg-Jessen C; Thomassen M; Burton M; Kruse TA; Kristensen BW
PLoS One; 2016; 11(7):e0159746. PubMed ID: 27454178
[TBL] [Abstract][Full Text] [Related]
11. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.
Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW
Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302
[TBL] [Abstract][Full Text] [Related]
12. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Yang Y; Hernandez R; Rao J; Yin L; Qu Y; Wu J; England CG; Graves SA; Lewis CM; Wang P; Meyerand ME; Nickles RJ; Bian XW; Cai W
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6525-34. PubMed ID: 26553993
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
[TBL] [Abstract][Full Text] [Related]
15. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
17. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
[TBL] [Abstract][Full Text] [Related]
18. Glioma spheroids obtained via ultrasonic aspiration are viable and express stem cell markers: a new tissue resource for glioma research.
Jensen SS; Aaberg-Jessen C; Andersen C; Schrøder HD; Kristensen BW
Neurosurgery; 2013 Nov; 73(5):868-86; discussion 886. PubMed ID: 23887192
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of ABCG2 in human malignant glioma].
Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
